Zobrazeno 1 - 10 of 460 pro vyhledávání: '"Wilcoxen K"'
1
Akademický článek
Erratum for Essalmani et al., "Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity".
Autor: Essalmani R; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Jain J; Laboratory of Human Retrovirology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Susan-Resiga D; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Andréo U; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada.; Laboratory of Human Retrovirology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Evagelidis A; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Derbali RM; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Huynh DN; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Dallaire F; Laboratory of Human Retrovirology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Laporte M; Laboratory of Human Retrovirology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Delpal A; AFMB, CNRS, Aix-Marseille Universitygrid.5399.6, CNRS, UMR 7257, Case 925, Marseille, France., Sutto-Ortiz P; AFMB, CNRS, Aix-Marseille Universitygrid.5399.6, CNRS, UMR 7257, Case 925, Marseille, France., Coutard B; Unité des Virus Emergents (UVE), Aix-Marseille Universitygrid.5399.6, IRD 190, INSERM 1207, IHU Méditerranée Infection, Marseille, France., Mapa C; Boston Pharmaceuticals, Translational Research, Cambridge, Massachusetts, USA., Wilcoxen K; Boston Pharmaceuticals, Translational Research, Cambridge, Massachusetts, USA., Decroly E; AFMB, CNRS, Aix-Marseille Universitygrid.5399.6, CNRS, UMR 7257, Case 925, Marseille, France., Pham TNQ; Laboratory of Human Retrovirology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Cohen ÉA; Laboratory of Human Retrovirology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada.; Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Quebec, Canada., Seidah NG; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada.
Publikováno v: Journal of virology [J Virol] 2022 Jul 13; Vol. 96 (13), pp. e0074522. Date of Electronic Publication: 2022 Jun 06.
Zobrazit plný text záznamu
2
Akademický článek
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Autor: Essalmani R; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Jain J; Laboratory of Human Retrovirology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Susan-Resiga D; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Andréo U; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada.; Laboratory of Human Retrovirology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Evagelidis A; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Derbali RM; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Huynh DN; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Dallaire F; Laboratory of Human Retrovirology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Laporte M; Laboratory of Human Retrovirology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Delpal A; AFMB, CNRS, Aix-Marseille University, CNRS, UMR 7257, Case 925, Marseille, France., Sutto-Ortiz P; AFMB, CNRS, Aix-Marseille University, CNRS, UMR 7257, Case 925, Marseille, France., Coutard B; Unité des Virus Émergents (UVE), Aix-Marseille University, IRD 190, INSERM 1207, IHU Méditerranée Infection, Marseille, France., Mapa C; Boston Pharmaceuticals, Translational Research, Cambridge, Massachusetts, USA., Wilcoxen K; Boston Pharmaceuticals, Translational Research, Cambridge, Massachusetts, USA., Decroly E; AFMB, CNRS, Aix-Marseille University, CNRS, UMR 7257, Case 925, Marseille, France., Nq Pham T; Laboratory of Human Retrovirology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada., Cohen ÉA; Laboratory of Human Retrovirology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada.; Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Quebec, Canada., Seidah NG; Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada.
Publikováno v: Journal of virology [J Virol] 2022 Apr 27; Vol. 96 (8), pp. e0012822. Date of Electronic Publication: 2022 Mar 28.
Zobrazit plný text záznamu
3
Akademický článek
391: Highly selective, first-in-class furin inhibitor BOS-318 inhibits ENaC and restores airway hydration in cystic fibrosis
Autor: Douglas, L., Reihill, J., Ho, M., Axten, J., Campobasso, N., Wilcoxen, K., Martin, S.
Publikováno v: In Journal of Cystic Fibrosis November 2021 20 Supplement 2:S185-S185
Zobrazit plný text záznamu
4
Akademický článek
Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme.
Autor: Hamilton MM; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Mseeh F; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., McAfoos TJ; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Leonard PG; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Reyna NJ; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Harris AL; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Xu A; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Han M; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Soth MJ; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Czako B; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Theroff JP; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Mandal PK; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Burke JP; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Virgin-Downey B; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Petrocchi A; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Pfaffinger D; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Rogers NE; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Parker CA; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Yu SS; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Jiang Y; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Krapp S; Proteros Biostructures GmbH, Bunsenstr. 7a, D-82152 Martinsried, Germany., Lammens A; Proteros Biostructures GmbH, Bunsenstr. 7a, D-82152 Martinsried, Germany., Trevitt G; XenoGesis Ltd, BioCity Nottingham, Pennyfoot Street, Nottingham, Nottinghamshire NG1 1GF, U.K., Tremblay MR; Tesaro Inc., 1000 Winter Street, Waltham, Massachusetts 02451 United States., Mikule K; Tesaro Inc., 1000 Winter Street, Waltham, Massachusetts 02451 United States., Wilcoxen K; Tesaro Inc., 1000 Winter Street, Waltham, Massachusetts 02451 United States., Cross JB; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Jones P; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Marszalek JR; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Lewis RT; IACS (Institute for Applied Cancer Science), University of Texas, MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2021 Aug 12; Vol. 64 (15), pp. 11302-11329. Date of Electronic Publication: 2021 Jul 22.
Zobrazit plný text záznamu
5
Akademický článek
Discovery of IACS-9439, a Potent, Exquisitely Selective, and Orally Bioavailable Inhibitor of CSF1R.
Autor: Czako B; IACS (Institute of Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Marszalek JR; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Burke JP; IACS (Institute of Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Mandal P; IACS (Institute of Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Leonard PG; IACS (Institute of Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Cross JB; IACS (Institute of Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Mseeh F; IACS (Institute of Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Jiang Y; IACS (Institute of Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Chang EQ; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Suzuki E; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Kovacs JJ; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Feng N; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Gera S; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Harris AL; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Liu Z; IACS (Institute of Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Mullinax RA; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Pang J; IACS (Institute of Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Parker CA; IACS (Institute of Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Spencer ND; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Yu SS; IACS (Institute of Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Wu Q; IACS (Institute of Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Tremblay MR; Tesaro Inc., 1000 Winter Street, Waltham, Massachusetts 02451, United States., Mikule K; Tesaro Inc., 1000 Winter Street, Waltham, Massachusetts 02451, United States., Wilcoxen K; Tesaro Inc., 1000 Winter Street, Waltham, Massachusetts 02451, United States., Heffernan TP; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States., Draetta GF; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States., Jones P; IACS (Institute of Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2020 Sep 10; Vol. 63 (17), pp. 9888-9911. Date of Electronic Publication: 2020 Aug 18.
Zobrazit plný text záznamu
6
Akademický článek
PARP Inhibitors in Brain Metastases from Epithelial Ovarian Cancer through a Multimodal Patient Journey: Case Reports and Literature Review.
Autor: Frezzini, Simona1 (AUTHOR) simona.frezzini@iov.veneto.it, Tasca, Giulia2 (AUTHOR) giulia.tasca@iov.veneto.it, Borgato, Lucia3 (AUTHOR) lucia.borgato@aulss8.veneto.it, Sartor, Lucia4 (AUTHOR) lucia.sartor@aulss6.veneto.it, Ferrero, Annamaria5 (AUTHOR) annamaria.ferrero@unito.it, Artioli, Grazia6 (AUTHOR) grazia.artioli@aulss2.veneto.it, Modena, Alessandra7 (AUTHOR) alessandra.modena@sacrocuore.it, Baldoni, Alessandra8 (AUTHOR) alessandra.baldoni@aulss3.veneto.it
Publikováno v: International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 14, p7887. 15p.
Zobrazit plný text záznamu
8
Akademický článek
311 - Discovery of TSR-022, a novel, potent anti-human TIM-3 therapeutic antibody
Autor: Murtaza, A., Laken, H., Da Silva Correia, J., McNeeley, P., Altobell, L., Zhang, J., Vancutsem, P., Wilcoxen, K., Jenkins, D.
Publikováno v: In European Journal of Cancer December 2016 69 Supplement 1:S102-S102
Zobrazit plný text záznamu
9
Akademický článek
310 - Identification and characterization of TSR-042, a novel anti-human PD-1 therapeutic antibody
Autor: Laken, H., Kehry, M., McNeeley, P., Neben, T., Zhang, J., Jenkins, D., Wilcoxen, K.
Publikováno v: In European Journal of Cancer December 2016 69 Supplement 1:S102-S102
Zobrazit plný text záznamu
10
Akademický článek
Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts.
Autor: Póti Á; Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary., Berta K; Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary., Xiao Y; Tesaro, Waltham, MA, USA., Pipek O; Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary., Klus GT; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Computational Health Informatics Program (CHIP), Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ried T; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Csabai I; Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary., Wilcoxen K; Tesaro, Waltham, MA, USA., Mikule K; Tesaro, Waltham, MA, USA., Szallasi Z; Computational Health Informatics Program (CHIP), Boston Children's Hospital, Boston, MA, USA. zoltan.szallasi@childrens.harvard.edu.; Harvard Medical School, Boston, MA, USA. zoltan.szallasi@childrens.harvard.edu.; Danish Cancer Society Research Center, Copenhagen, Denmark. zoltan.szallasi@childrens.harvard.edu.; MTA-SE-NAP, Brain Metastasis Research Group, 2nd Department of Pathology, Semmelweis University, Budapest, Hungary. zoltan.szallasi@childrens.harvard.edu., Szüts D; Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary. szuts.david@ttk.mta.hu.
Publikováno v: British journal of cancer [Br J Cancer] 2018 Nov; Vol. 119 (11), pp. 1392-1400. Date of Electronic Publication: 2018 Nov 14.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje